Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison

BACKGROUND: The preventive treatment of Plasmodium vivax relapse recommended by the World Health Organization is primaquine at a dose of 15 mg/day for 14 days, except for malaria cases from Asia and Oceania. Since 2006, CDC recommends the use of primaquine at 30 mg/day for 14 days. In France, all ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdes, Audrey, Epelboin, Loic, Mosnier, Emilie, Walter, Gaelle, Vesin, Guillaume, Abboud, Philippe, Melzani, Alessia, Blanchet, Denis, Blaise, Nicaise, Nacher, Mathieu, Demar, Magalie, Djossou, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009032/
https://www.ncbi.nlm.nih.gov/pubmed/29921273
http://dx.doi.org/10.1186/s12936-018-2378-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009032/
https://www.ncbi.nlm.nih.gov/pubmed/29921273
http://dx.doi.org/10.1186/s12936-018-2378-2

Ejemplares similares